Hemab Therapeutics Holdings, Inc. Common Stock (COAG) vs Taysha Gene Therapies, Inc. (TSHA)

A side-by-side comparison of Hemab Therapeutics Holdings, Inc. Common Stock and Taysha Gene Therapies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Hemab Therapeutics Holdings, Inc. Common Stock logo
COAG
Hemab Therapeutics Holdings, Inc. Common Stock
$1.33B
$28.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Taysha Gene Therapies, Inc. logo
TSHA
Taysha Gene Therapies, Inc.
$1.40B
$4.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — COAG vs TSHA

growth of $100 · dividends reinvested · last 1y
COAG -10.0% (-10.0%/yr)TSHA -29.1% (-29.1%/yr)COAG compounded faster over this window
80100120140160Start $100$90$71
COAG TSHA

COAG vs TSHA: by the numbers

  • •TSHA is the larger company ($1.40B vs $1.33B market cap).
  • •Both run net losses; COAG's is the smaller (0.00% vs -2728.04% net margin).

Metrics side by side

Valuation

MetricCOAGTSHA
P/S ratioN/A256.01
P/B ratio2.923.63

Profitability

MetricCOAGTSHA
Gross margin0.00%100.00%
Operating margin0.00%-1130.65%
Net margin0.00%-2728.04%
ROEN/A-38.64%
ROIC-38.09%-34.46%

Growth (annualized)

MetricCOAGTSHA
Total return CAGR (5Y)N/A-25.17%

Go deeper

Full COAG analysisFull TSHA analysisInteractive comparison tool

Dig into the metrics

Hemab Therapeutics Holdings, Inc. Common Stock ROETaysha Gene Therapies ROEHemab Therapeutics Holdings, Inc. Common Stock operating marginTaysha Gene Therapies operating marginHemab Therapeutics Holdings, Inc. Common Stock revenue growthTaysha Gene Therapies revenue growthHemab Therapeutics Holdings, Inc. Common Stock free cash flowTaysha Gene Therapies free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.